TRIM21 and xerostomia: Consistently, in the present study, patients with both anti-Ro52 and anti-Ro60 reactivity were more likely to experience xerophthalmia and xerostomia and also had a significantly higher anti-La positivity compared with the patients with isolated anti-Ro60 or anti-Ro52 positivity.